Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06292169 · ClinicalTrials.gov registry record · NA
Pectoralis Minor Release Versus Non-release in RSA
A NA study of Rotator Cuff Tear Arthropathy and Reverse Total Shoulder Arthroplasty, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 2
- Study locations
NCT06292169: Recruiting NA study of Rotator Cuff Tear Arthropathy and Reverse Total Shoulder Arthroplasty, sponsored by Emory University.
NCT06292169 is a NA study of Rotator Cuff Tear Arthropathy and Reverse Total Shoulder Arthroplasty that is actively recruiting participants, run by Emory University. The registered enrollment target is 90 participants, below the 3,447-participant average among 6 other Rotator Cuff Tear Arthropathy trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06292169, a NA study of Rotator Cuff Tear Arthropathy and Reverse Total Shoulder Arthroplasty, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to assess if concomitant open pectoralis minor release would improve pain and outcomes after Reverse Shoulder Arthroplasty (RSA). The main questions it aims to answer are: * whether releasing the pectoralis minor prophylactically could have better pain relief * whether releasing the pectoralis minor prophylactically could have increased Range of motion (ROM) outcomes * whether releasing the pectoralis minor prophylactically could have higher final Patient Reported Outcome Measurements (PROMs) Participants will be randomized to either undergo RSA with pectoralis minor release or RSA without pectoralis minor release.
Primary Outcome
The Visual Analogue Scale (VAS) measures pain intensity. The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). Study participants will be asked to rate their current level of pain by placing a mark on the line
Conditions Studied
Interventions
- PROCEDURE Pectoralis Minor Release
- PROCEDURE RSA
Study Locations (2)
Georgia
- Emory Clinic - Atlanta
- Emory Healthcare Orthopaedics and Spine Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-08-07 |
| Est. Completion | 2026-01 |
| Phase | NA |
What NCT06292169 shows while recruiting
NCT06292169 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 3,447-participant average among 6 other Rotator Cuff Tear Arthropathy trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Rotator Cuff Tear Arthropathy appearing as the primary indexed condition, and to 2 interventions - of which Pectoralis Minor Release is the first listed.
NCT06292169 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06292169 about?
NCT06292169 is a clinical study titled "Pectoralis Minor Release Versus Non-release in RSA". The goal of this clinical trial is to assess if concomitant open pectoralis minor release would improve pain and outcomes after Reverse Shoulder Arthroplasty (RSA). The main questions it aims to answer are: * whether releasing the pectoralis minor prophylactically could have better pain relief * wh...
What is the current status of trial NCT06292169?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-08-07. Estimated completion is 2026-01.
What conditions does trial NCT06292169 study?
This clinical trial studies the following conditions: Rotator Cuff Tear Arthropathy, Reverse Total Shoulder Arthroplasty, Advanced Glenohumeral Osteoarthritis.
What interventions are being tested in trial NCT06292169?
The interventions under investigation include: Pectoralis Minor Release (PROCEDURE), RSA (PROCEDURE).
Who is sponsoring clinical trial NCT06292169?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06292169 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rotator Cuff Tear Arthropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sling vs No Sling After Reverse Total Shoulder Arthroplasty
ACTIVE NOT RECRUITING · NA
-
Telerehabilitation After Shoulder Arthroplasty
ACTIVE NOT RECRUITING · NA
-
Effect of Ibuprofen on Postoperative Opiate Medication Use and Shoulder Functional Outcomes
COMPLETED · NA
-
Bioinductive Patch for Full-Thickness Rotator Cuff Tears
RECRUITING · Phase 4
-
Perform Humeral System Study
RECRUITING
-
Exactech Shoulder Post Market Clinical Follow-up Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI